Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Prendiville

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routes in patients with advanced cancer--a phase I toxicity study and pharmacokinetic analysisJ Prendiville, N Thatcher, M Lind, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 1999
Surgery plus chemotherapy or chemotherapy alone for primary intermediate- and high-grade gastric non-Hodgkin's lymphoma: the Royal Marsden Hospital experienceR A Popescu, A C Wotherspoon, D Cunningham, et al.
Theriogenology|January 1, 1994
Interaction between dietary intake and ovariectomy on concentrations of insulin-like growth factor-I, GH and LH in plasma of heifersW J Enright, L J Spicer, D J Prendiville, et al.
Journal of Animal Science|July 1, 1994
Active immunization against prostaglandin F2 alpha: effect of conjugate dose and booster interval on antibody titers and estrous behavior in postpubertal beef heifersM A Crowe, W J Enright, D J Prendiville, et al.
European Cytokine Network|May 1, 1993
A phase I study of recombinant human interleukin-4 administered by the intravenous and subcutaneous route in patients with advanced cancer: immunological studiesA K Ghosh, N K Smith, J Prendiville, et al.
Journal of Animal Science|August 1, 1995
Immunization of heifers against gonadotropin-releasing hormone: antibody titers, ovarian function, body growth, and carcass characteristicsD J Prendiville, W J Enright, M A Crowe, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 1994
Immunomodulation in patients receiving intravenous Bryostatin 1 in a phase I clinical study: comparison with effects of Bryostatin 1 on lymphocyte function in vitroC Scheid, J Prendiville, G Jayson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Bryostatin 1 induces productive Epstein-Barr virus replication in latently infected cells: implications for use in immunocompromised patientsJ P Stewart, A T McGown, J Prendiville, et al.
The Cochrane Database of Systematic Reviews|April 2, 2013
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesionsMarc Arbyn, Jolien Roelens, Cindy Simoens, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I/II study of intraperitoneal iproplatin in patients with minimal residual disease following platinum-based systemic therapy for epithelial ovarian carcinomaD Murphy, M J Lind, J Prendiville, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routes in patients with advanced cancer--a phase I toxicity study and pharmacokinetic analysisJ Prendiville, N Thatcher, M Lind, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 1999
Surgery plus chemotherapy or chemotherapy alone for primary intermediate- and high-grade gastric non-Hodgkin's lymphoma: the Royal Marsden Hospital experienceR A Popescu, A C Wotherspoon, D Cunningham, et al.
Theriogenology|January 1, 1994
Interaction between dietary intake and ovariectomy on concentrations of insulin-like growth factor-I, GH and LH in plasma of heifersW J Enright, L J Spicer, D J Prendiville, et al.
Journal of Animal Science|July 1, 1994
Active immunization against prostaglandin F2 alpha: effect of conjugate dose and booster interval on antibody titers and estrous behavior in postpubertal beef heifersM A Crowe, W J Enright, D J Prendiville, et al.
European Cytokine Network|May 1, 1993
A phase I study of recombinant human interleukin-4 administered by the intravenous and subcutaneous route in patients with advanced cancer: immunological studiesA K Ghosh, N K Smith, J Prendiville, et al.
Journal of Animal Science|August 1, 1995
Immunization of heifers against gonadotropin-releasing hormone: antibody titers, ovarian function, body growth, and carcass characteristicsD J Prendiville, W J Enright, M A Crowe, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 1994
Immunomodulation in patients receiving intravenous Bryostatin 1 in a phase I clinical study: comparison with effects of Bryostatin 1 on lymphocyte function in vitroC Scheid, J Prendiville, G Jayson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Bryostatin 1 induces productive Epstein-Barr virus replication in latently infected cells: implications for use in immunocompromised patientsJ P Stewart, A T McGown, J Prendiville, et al.
The Cochrane Database of Systematic Reviews|April 2, 2013
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesionsMarc Arbyn, Jolien Roelens, Cindy Simoens, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I/II study of intraperitoneal iproplatin in patients with minimal residual disease following platinum-based systemic therapy for epithelial ovarian carcinomaD Murphy, M J Lind, J Prendiville, et al.
Pageof 9